Check out the changes to the WADA 2027 anti-doping list and what happens with semaglutide, tirzepatide, cannabinoids, and ...
Among patients with COPD and type 2 inflammation at an urgent outpatient visit, the ED or hospital, a single dose of add-on rademikibart vs. placebo lowered treatment failure through 4 weeks, ...
A single injection of the next-generation drug rademikibart markedly cut the rate and impact of acute exacerbations among ...
AstraZeneca’s tozorakimab reduced disease flare ups in patients with COPD, suggesting IL-33-targeted antibodies could offer broad potential in pulmonary diseases.
Connect Biopharma has pointed to phase 2 data for its IL-4/IL-13 blocker as proof that the wannabe Dupixent rival can reduce ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CLEVELAND, Ohio — When we hear that a friend has breast cancer, we know they’re in for a rough patch but will probably be fine in the end. The reaction is very different if the diagnosis is aggressive ...
Novel therapies and advances in conventional treatments have improved care for many patients in recent years. And they've also changed how some primary care physicians (PCPs) have approached certain ...
Now we are indeed talking. The War On Drugs returned last month with "Who's That," their first new single in four years, and it lived up to our lofty expectations. The band is out on the road right ...
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored ...
The three obesity newcomers arrive at Novo during a time of renewal, with the Danish drug giant recently announcing a brand refresh that dropped the “Nordisk” from the company’s everyday moniker.
Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to the American Society of Health-System Pharmacists. Nearly half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results